Synthesis and biological activities of NB-506 analogues modified at the glucose group
作者:Mitsuru Ohkubo、Teruyuki Nishimura、Hiroshi Kawamoto、Masato Nakano、Teruki Honma、Tomoko Yoshinari、Hiroharu Arakawa、Hiroyuki Suda、Hajime Morishima、Susumu Nishimura
DOI:10.1016/s0960-894x(00)00004-4
日期:2000.3
A new indolocarbazole compound, NB-506 (1), modified at the glucose group yielded a beta-D-glucopyranoside, J-107,088 (2), which showed potent anticancer activity. A beta-D-ribofuranoside, J-109,534 (3), was found to be 6 times more potent than J-107,088 at inhibiting topoisomerase I.
在葡萄糖基团上修饰的新吲哚并咔唑化合物NB-506(1)产生了β-D-吡喃葡萄糖苷J-107,088(2),该化合物具有强大的抗癌活性。发现β-D-核呋喃糖苷J-109,534(3)在抑制拓扑异构酶I方面的效力是J-107,088的6倍。